As of Wednesday, Applied Therapeutics Inc.’s (NASDAQ:APLT) stock closed at $0.89, up from $0.85 the previous day. While Applied Therapeutics Inc. has overperformed by 4.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, APLT fell by -91.77%, with highs and lows ranging from $11.87 to $0.50, whereas the simple moving average fell by -36.49% in the last 200 days.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
On January 04, 2022, Barclays Downgraded Applied Therapeutics Inc. (NASDAQ: APLT) to Equal Weight. A report published by Goldman on August 27, 2021, Downgraded its rating to ‘Sell’ for APLT. Goldman also rated APLT shares as ‘Neutral’, setting a target price of $18 on the company’s shares in an initiating report dated June 25, 2021. Truist Initiated an Buy rating on October 08, 2020, and assigned a price target of $85. Goldman initiated its ‘Buy’ rating for APLT, as published in its report on April 22, 2020. Barclays’s report from February 27, 2020 suggests a price prediction of $64 for APLT shares, giving the stock a ‘Overweight’ rating. Robert W. Baird also rated the stock as ‘Outperform’.
Analysis of Applied Therapeutics Inc. (APLT)
One of the most important indicators of Applied Therapeutics Inc.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -272.20% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.20, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and APLT is recording 317.26K average volume. On a monthly basis, the volatility of the stock is set at 12.89%, whereas on a weekly basis, it is put at 12.69%, with a gain of 4.71% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.50, showing growth from the present price of $0.89, which can serve as yet another indication of whether APLT is worth investing in or should be passed over.
How Do You Analyze Applied Therapeutics Inc. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.30%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 57.00% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in APLT shares?
The recent increase in stakes in APLT appears to be a result of several institutional investors and hedge funds increasing their positions. Alyeska Investment Group LP made another decreased to its shares in APLT during the first quarter, downing its stake by -26.26%. During the last quarter, the company dropped down -1,144,477 additional shares for a total stake of worth $2.49 million, bringing number of shares owned by the company to 3,213,213.
During the first quarter, Fidelity Management & Research Co subtracted a -803,306 position in APLT. Point72 Asset Management LP sold an additional -1.12 million shares in the last quarter, decreasing its holdings by -39.33%, now holding 1.72 million shares worth $1.33 million. APLT shares are owned by institutional investors to the tune of 57.00% at present.